Vendavo, a leading provider of commercial excellence solutions, announced today the company has been listed in the Gartner “Market Guide for B2B Price Optimization and Management Software” for 2019.
As outlined in the report, Gartner states “PO&M software plus related services grew by 18% in 2018 to $345 million.” And further, Gartner estimates “about 981 companies had deployed PO&M software at the end of 2018. This is an increase of 30% from 2017.”
“We continue to see growing interest in price optimization and management, particularly among forward-thinking B2B organizations who are faced with the challenges brought on by shifting customer expectations,” said Bruno Slosse, Vendavo President and CEO. “It’s a way to deliver value to the customer, and the organization’s own bottom line.”
Also in the report within the Market Direction section, Gartner states that it expects “the PO&M market to continue to grow rapidly during the next three years,” driven by several key factors, two of which include: “PO&M software has a rapid payback on investment (often less than six months)” and “PO&M technology will be increasingly available as part of cloud CPQ solutions.”
“With the acquisition of Navetti in 2018, we brought together the dynamic price management and optimization capabilities of the Pricepoint solution, with the already robust capabilities in Vendavo’s CPQ, analytics, and optimization solutions. We feel the value of this decision was substantiated in this report,” Slosse said.
The Gartner report referenced is: “Market Guide for B2B Price Optimization and Management Software” (27 March, 2019) by Mark Lewis.
View a complimentary copy of the Market Guide here.
Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.